Recurrent reversible mutations at gaf1 driving metastable TORC1 inhibitor resistance in fission yeast.
What this study shows
Metastable resistance to TORC1 inhibitors (rapamycin plus caffeine) in fission yeast is driven by recurrent, spontaneously reversible loss-of-function mutations in gaf1, a GATA transcription factor and negative growth regulator downstream of TORC1 - a genetic (not epigenetic) toggle that can silently contaminate lab yeast stocks.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Fission yeast (Schizosaccharomyces pombe)) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Fission yeast (Schizosaccharomyces pombe) |
| Journal | Microbiology Spectrum |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1128/spectrum.01467-26 · PMID 42752201 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | rapamycin plus caffeine selection; gaf1 loss-of-function and wild-type allele restoration |
| Target | TORC1 signalling output via the GATA transcription factor Gaf1 |
| Model | fission yeast (Schizosaccharomyces pombe) |
| Effect | Reversible loss-of-function mutations in gaf1 were necessary and sufficient for metastable resistance to TORC1 inhibition, with derepression of translation and metabolic programmes on drug treatment. |
In the Atlas
Related topics
Was this page useful?
Thank you. Your answer was counted anonymously.